Hoth Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	5	6	10	16	32	63
Market Cap Growth	-1.60%	-38.29%	-35.89%	-50.32%	-49.16%	-
Enterprise Value	-3	-3	4	5	27	60
PE Ratio	-	-0.80	-0.89	-1.11	-4.42	-8.13
PB Ratio	0.60	0.71	1.98	1.60	6.86	26.14
P/FCF Ratio	-0.85	-0.74	-1.09	-1.31	-5.19	-12.66
P/OCF Ratio	-0.85	-0.74	-1.09	-1.31	-5.19	-12.66
EV/EBITDA Ratio	0.11	0.38	-0.31	-0.37	-3.77	-7.78
EV/EBIT Ratio	0.11	0.38	-0.31	-0.37	-3.77	-7.78
EV/FCF Ratio	0.10	0.35	-0.38	-0.44	-4.43	-12.12
Debt / Equity Ratio	0.01	0.01	-	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-	-	-	-
Debt / FCF Ratio	-0.01	-0.01	-	-	-	-
Quick Ratio	11.82	13.69	4.78	12.08	15.03	6.12
Current Ratio	13.14	13.89	4.85	12.19	15.32	5.99
Return on Equity (ROE)	-83.00%	-76.30%	-138.50%	-95.60%	-132.80%	-189.50%
Return on Assets (ROA)	-73.30%	-66.80%	-120.20%	-87.60%	-120.10%	-180.70%
Return on Capital (ROIC)	-95.85%	-86.72%	-216.05%	-142.69%	-157.18%	-321.99%
Earnings Yield	-162.78%	-125.35%	-112.11%	-90.27%	-22.60%	-12.30%
FCF Yield	-166.57%	-134.96%	-91.67%	-76.42%	-19.26%	-7.90%
Buyback Yield / Dilution	-77.17%	-184.69%	-34.07%	-80.63%	-34.90%	-82.16%
Total Shareholder Return	-77.17%	-184.69%	-34.07%	-80.63%	-34.90%	-82.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).